The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II multi-center study of sintilimab in combination with axitinib in patients with advanced fumarate hydratase-deficient renal cell carcinoma.
 
Xingming Zhang
No Relationships to Disclose
 
Haoyang Liu
No Relationships to Disclose
 
Yaowen Zhang
No Relationships to Disclose
 
Junjie Zhao
No Relationships to Disclose
 
Yuntian Chen
No Relationships to Disclose
 
Guangxi Sun
No Relationships to Disclose
 
Xinan Sheng
Speakers' Bureau - BeiGene; Junshi Pharmaceuticals; Novartis; Pfizer; RemeGen
 
Yongquan Wang
No Relationships to Disclose
 
Kan Gong
No Relationships to Disclose
 
Xiaodong Liu
No Relationships to Disclose
 
Rui Huang
No Relationships to Disclose
 
Qiang Wei
No Relationships to Disclose
 
Xiang Li
No Relationships to Disclose
 
Jiyan Liu
No Relationships to Disclose
 
Pengfei Shen
No Relationships to Disclose
 
Ni Chen
No Relationships to Disclose
 
Jin Yao
No Relationships to Disclose
 
Zhenhua Liu
No Relationships to Disclose
 
Hao Zeng
No Relationships to Disclose